Streetbeat News

Price Targets

AESI

Stephens & Co. analyst Mike Scialla has reiterated an Overweight rating on Atlas Energy Solutions (NYSE:AESI) and maintained a $23 price target.

Portfolio Pulse from richadhand@benzinga.com

July 06, 2023 | 11:36 am

PB

Raymond James analyst Michael Rose has maintained an 'Outperform' rating on Prosperity Bancshares (NYSE:PB) but lowered the price target from $70 to $65.

Portfolio Pulse from richadhand@benzinga.com

July 06, 2023 | 11:34 am

HBAN

Raymond James analyst David Long has maintained a 'Strong Buy' rating on Huntington Bancshares (NASDAQ:HBAN), but lowered the price target from $15 to $14.

Portfolio Pulse from richadhand@benzinga.com

July 06, 2023 | 11:33 am

CMA

Raymond James analyst Michael Rose has maintained a 'Strong Buy' rating on Comerica (NYSE:CMA), but lowered the price target from $57 to $53.

Portfolio Pulse from richadhand@benzinga.com

July 06, 2023 | 11:32 am

RGEN

RBC Capital analyst Conor McNamara has upgraded Repligen (NASDAQ:RGEN) from Sector Perform to Outperform and announced a price target of $156.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 11:28 am

NYCB

Raymond James analyst William Wallace maintains a Strong Buy rating on New York Community (NYSE:NYCB) and raises the price target from $13 to $14.

Portfolio Pulse from richadhand@benzinga.com

July 06, 2023 | 11:27 am

GNTX

B of A Securities analyst John Murphy has upgraded Gentex (NASDAQ:GNTX) from Underperform to Neutral and raised the price target from $26 to $33.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 11:23 am

GNTX

B of A Securities analyst John Murphy has upgraded Gentex (NASDAQ:GNTX) from Underperform to Neutral and lowered the price target from $26 to $23.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 11:22 am

SAWLF

National Bank Financial Inc's analyst Zachary Evershed has maintained an Outperform rating on Shawcor (OTC:SAWLF) and raised the price target from C$18 to C$24.5.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 11:14 am

CME

Rosenblatt analyst Andrew Bond maintains a 'Sell' rating on CME Group (NASDAQ:CME) but raises the price target from $161 to $169.

Portfolio Pulse from richadhand@benzinga.com

July 06, 2023 | 11:01 am